EcoDrugPlus

Cathepsin S

Ensembl ID : ENSPTIG00000001310
Gene Symbol: CTSS
2 Cross references
269 Possible Orthologues:

Cell Division Cycle 7

Ensembl ID : ENSPTIG00000006650
Gene Symbol: CDC7
2 Cross references
208 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSPTIG00000013941
Gene Symbol: CHEK1
2 Cross references
177 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSPTIG00000019047
Gene Symbol: CHEK2
2 Cross references
205 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSPTIG00000005490
Gene Symbol: CCKAR
2 Cross references
200 Possible Orthologues:

Cholecystokinin B Receptor

Ensembl ID : ENSPTIG00000017427
Gene Symbol: CCKBR
1 Cross references
264 Possible Orthologues:

Cholinergic Receptor Muscarinic 1

Ensembl ID : ENSPTIG00000007102
Gene Symbol: CHRM1
2 Cross references
101 Possible Orthologues:

Cholinergic Receptor Muscarinic 2

Ensembl ID : ENSPTIG00000007043
Gene Symbol: CHRM2
2 Cross references
259 Possible Orthologues:

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSPTIG00000005811
Gene Symbol: CHRM3
2 Cross references
255 Possible Orthologues:

Cholinergic Receptor Muscarinic 4

Ensembl ID : ENSPTIG00000009949
Gene Symbol: CHRM4
2 Cross references
184 Possible Orthologues:

Cholinergic Receptor Muscarinic 5

Ensembl ID : ENSPTIG00000002910
Gene Symbol: CHRM5
2 Cross references
263 Possible Orthologues:

Cholinergic Receptor Nicotinic Alpha 3 Subunit

Ensembl ID : ENSPTIG00000018676
Gene Symbol: CHRNA3
2 Cross references
207 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).